Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




COV, PWRM, MSFT, CSRH, NKE, CVAT, ABT, DrStockPick.com Stock Report!

Dr. Stock Pick (September 30th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

Wednesday September 30, 2009

DrStockPick.com Stock Report!

COV, PWRM, MSFT, CSRH, NKE, CVAT, ABT

**************************************************************

COV, Covidien plc

COV engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings worldwide. The company operates through four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products, and Medical Supplies.

COV said Wednesday it received Food and Drug Administration clearance for its new endotracheal tube, a device that helps patients breathe.

**************************************************************

PWRM, Power 3 Medical Products Inc, PWRM.OB

Power3 Medical Products, Inc. is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the

...
More »
Tags for this Post:
Abbott Laboratories, ABT, accessory products, adult and pediatric pharmaceuticals, advertisement services, advertising services, ALS, anemia, anesthesia products, ankylosing spondylitis;, anti-infectives, apparel, Asia, Baseball, basketball, Beijing, beverage, bipolar disorder, Breast Cancer, broker, cancer, Cavitation Technologies Inc., ceo, Chair and Keynote Speaker, Charles Mandeville, chemical industries, Chemist, chief scientific officer, China, Congress, Consorteum Holdings Inc.;, Covidien plc, credit card transaction processing, Crown Equity Holdings Inc.;, CSRH, diagnostic tests, Dr Stock Pick, dyslipidemia;, Electricity, electronic transaction processing;, endometriosis, Energy Costs, epilepsy, equipment, equity trader, Federal judge, Financial Services, food, Food And Drug Administration, football, Footwear, golf, hardware products;, health care products, healthcare, healthcare products, HIV infection, Houston, hypothyroidism, International Congress, Investing Lessons, Ira Goldknopf, leader in the development, Media Center, Microsoft Corporation, migraines;, Moberly, neurodegenerative disease;, Nike Inc, North America, obesity, outdated technologies, payment processing industry, Power 3 Medical Products Inc., Power3 Medical Products Inc.;, Power3;, precocious puberty, president, President & COO, producer, professional investment analyst and consultant, Prostate Cancer, psoriasis, psoriatic arthritis;, Quent Rickerby;, Rheumatoid Arthritis, Rhode Island, Roman Gordon, secondary hyperparathyroidism, skateboarding, soccer, South America, SRS Engineering Inc., stock featured on our site;, Stock Pick, Stocks to Watch, systems, systems technologies, technology solutions, tennis, Texas, transaction processing industries;, transactional processing systems;, USD, uterine fibroids;, vegetable oil refining, volleyball, wall street, Windows Vista, Windows XP, wrestling, www.consorteum.com, www.crowntradingsystems.com, www.crwenews.com, www.drstockpick.com, www.pcsoyenergy.com, www.power3medical.com, www.processconcepts.com, www.srsengineering.com, www.stock-ir.com

Posted in Investing Lessons, Stocks to Watch | 3 Comments »

XRX, PWRM, ABT, CSRH, CMCSA, CVAT, FMCN, DrStockPick.com Stock Report!

Dr. Stock Pick (September 28th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

Monday September 28, 2009

DrStockPick.com Stock Report!

XRX, PWRM, ABT, CSRH, CMCSA, CVAT, FMCN

**************************************************************

XRX, Xerox Corp.

XRX engages in the development, manufacture, marketing, servicing, and financing of document equipment, software, solutions, and services worldwide.

XRX said Monday it will buy Affiliated Computer Services Inc. for $6.4 billion in cash and stock to create a $22 billion business that combines XRX’s copiers, printers and document management services with the “business process outsourcing” of Dallas-based ACS., joining the expensive race among technology companies to broaden their offerings.

**************************************************************

PWRM, Power 3 Medical Products Inc, PWRM.OB

Power3 Medical Products, Inc. is a leading bio-medical company engaged in

...
More »
Tags for this Post:
Abbott Laboratories, ABT, adult and pediatric pharmaceuticals, advertisement services, advertising services, Affiliated Computer Services Inc., ALS, anemia, anesthesia products, ankylosing spondylitis;, anti-infectives, Argentina, Beijing, beverage, bipolar disorder, Breast Cancer, broker, cable services;, cancer, Cavitation Technologies Inc., ceo, Chair and Keynote Speaker, chemical industries, chemicals maker;, chief scientific officer, China, Chinese Ministry of Commerce, Comcast Corporation;, communication products, communications products, Congress, Consorteum Holdings Inc.;, credit card transaction processing, Crown Equity Holdings Inc.;, CSRH, Cupertino;, Dallas, diagnostic tests, digital media, digital out-of-home advertising networks, document equipment, document management services, Dow Chemical, Dr Stock Pick, dyslipidemia;, electronic transaction processing;, endometriosis, epilepsy, equity trader, Fda, Financial Services, Focus Media Holding Ltd., food, health care products, healthcare, HIV infection, Houston, hypothyroidism, International Congress, Investing Lessons, Ira Goldknopf, Latin America, leader in the development, Los Altos, migraines;, Milpitas, mobile handset advertising, Mountain View, neurodegenerative disease;, North America, obesity, out-of-home advertising network, outdated technologies, Palo Alto;, payment processing industry, Pharmaceutical, Power 3 Medical Products Inc., Power3 Medical Products Inc.;, Power3;, precocious puberty, president, President & COO, professional investment analyst and consultant, Prostate Cancer, psoriasis, psoriatic arthritis;, Quent Rickerby;, Rheumatoid Arthritis, Ricoh XR-X 3PF Film Camera;, Roman Gordon, San Francisco, San Rafael, Santa Clara, Saratoga, secondary hyperparathyroidism, SINA Corporation;, Solvay, stock featured on our site;, Stock Pick, Stocks to Watch, Sunnyvale, Technology, technology solutions, Texas, transaction processing industries;, transactional processing systems;, United States, USD, uterine fibroids;, Vacaville, vegetable oil refining, www.alsbio.com, www.consorteum.com, www.crowntradingsystems.com, www.crwenews.com, www.dow.com, www.drstockpick.com, www.power3medical.com, www.stock-ir.com, Xerox Corp.;, XRX

Posted in Investing Lessons, Stocks to Watch | No Comments »

Hospira Injection Gets FDA Clearance – Analyst Blog

Zacks Market Commentaries (June 30th, 2009) Writes:

Hospira (HSP) recently obtained approval for its anti-infective Azithromycin injection from the U.S. Food and Drug Administration (FDA). Azithromycin is a generic variant of Pfizer's (PFE) Zithromax and is ADD-Vantage system compatible.

ADD-Vantage is an advanced drug delivery system that does not need a needle and syringe to mix the drug with the solution. This lowers the risk of accidental needle pricks, improves workflow and prevents waste due to stability and shelf-life elements. Hospira is the first company to offer Azithromycin in an advanced drug delivery system. U.S. sales of generic and name-brand Azithromycin injection amounted to nearly $40 million in 2008.

Hospira's specialty injectable pharmaceuticals (SIP) portfolio comprises of nearly 200 generic injectable drugs across multiple therapeutic areas including anesthesia, anti-infectives, analgesics, cardiovascular and oncology. SIP accounted for 50% of the total revenues of the company in 2008. We expect SIP to continue to drive

...
More »

Posted in Market Commentary, Stocks to Watch | No Comments »

Highest Yielding Big Pharma Stocks

Fred Fuld (October 20th, 2008) Writes:
Investors turn to the large drug company stocks for several reasons. They are considered recession proof, they are a play on the ageing of the baby boomers, and they are often considered safer and less volatile than most other stocks. Since dividends are so vital to many investors they days, the high yielding big pharmas are of interest. All of the following have yields over 2.5%, PE's below 20, and PEGs below 3.Pfizer Inc. (PFE) Its drugs include Lipitor, Norvasc Caduet, Chantix/Champix, Lyrica, Geodon/Zeldox, Aricept, Zoloft, Celebrex, Vfend, Zyvox, Viagra, Detrol, and Zyrtec, and for animals; Clavamox/Synulox, RespiSureOne/StellamuneOne, Bovi-Shield Gold, Dectomax, and Draxxin. The stock yields 7.5% It has a PE of 12.7 and a PEG of 2.12 .Bristol Myers Squibb Co. (BMY) Its drugs include PLAVIX, AVAPRO/AVALIDE, PRAVACHOL, COUMADIN, REYATAZ, SUSTIVA, BARACLUDE, ERBITUX, TAXOL, SPRYCEL, IXEMPRA, ABILIFY, ORENCIA, and EFFERALGAN. The ...
More »

Posted in Current Market News, Stocks to Watch | No Comments »

York Pharma (YRK.L) – acquires anti-infective topical derm line from Solvay

Gabriel Didham (July 7th, 2008) Writes:
Reason for comment York Pharma have announced the acquisition of the sales and worldwide commercial rights to two dermatological products from the Belgian Pharmaceutical and Chemical Company Solvay for a total consideration of €28.5m.

The products are Flammazine® and Flammacerium®, both brands are established in Europe for the prevention of infection in burns and topical wounds. The agreement with Solvay entails the transfer of the brands, any IP and sales on a worldwide basis as well as an associated 5 year supply contract of finished product from Solvay.

These silver-based sulfadiazine (anti-bacterial) products are approved in 21 countries although sales of the product are concentrated in France, Germany, Belgium and Spain. York estimates that the global market for topical anti-infectives is valued around US$450million with the current sales of these products around the $17.2 million (£ 8.7 million) mark or a penetration of 3.8%.

To finance this acquisition, York has

...
More »

Posted in Small & Micro Cap, Stocks to Watch | No Comments »


Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.